{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:31:16Z","timestamp":1793320276181,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:00:00Z","timestamp":1793318400000},"content-version":"vor","delay-in-days":115,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shandong Provincial Natural Science Foundation of China","award":["ZR2024MH243"],"award-info":[{"award-number":["ZR2024MH243"]}]},{"name":"Shandong Provincial Natural Science Foundation of China","award":["ZR2021MH164"],"award-info":[{"award-number":["ZR2021MH164"]}]},{"name":"Cultivation Plan for High Level Scientific Research Projects of Jining Medical University","award":["JYGC2022KJ006"],"award-info":[{"award-number":["JYGC2022KJ006"]}],"id":[{"id":"https:\/\/ror.org\/03zn9gq54","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Cultivation Plan for High Level Scientific Research Projects of Jining Medical University","award":["JYGC2023KJ009"],"award-info":[{"award-number":["JYGC2023KJ009"]}],"id":[{"id":"https:\/\/ror.org\/03zn9gq54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lumican, an extracellular matrix (ECM) component highly expressed in placenta, is implicated in preeclampsia (PE) pathogenesis, though its precise mechanisms in trophoblast function and PE development remain unclear. Transcriptomic analysis of a PE rat model induced by L-NAME revealed altered placental gene expression. Lumican expression progressively increased throughout rat and human gestation but was significantly downregulated in PE patient and model placentas. Functional assays showed shRNA-mediated\n                    <jats:italic>lumican<\/jats:italic>\n                    knockdown inhibited trophoblast proliferation, migration, and invasion while promoting apoptosis. This knockdown also influenced the phosphorylation of key proteins within the PI3K\/AKT and P53 signaling pathways. Co-treatment with the PI3K agonist 740 Y-P activated this pathway, enhancing trophoblast proliferation and invasion, effects antagonized by\n                    <jats:italic>lumican<\/jats:italic>\n                    knockdown. In vivo, adenovirus-mediated\n                    <jats:italic>lumican<\/jats:italic>\n                    shRNA induced PE-like phenotypes: elevated systolic blood pressure, increased 24\u2009h urinary protein, higher plasma sFlt-1 levels and sFlt-1\/PlGF ratio. Histopathological analyses demonstrated abnormal placental villi development and renal glomerular endothelial damage. Immunohistochemistry confirmed lumican deficiency reduced PI3K, AKT, and MDM2 while upregulating P53 in placental tissues. Collectively, our findings demonstrate that reduced lumican expression contributes to PE by impairing trophoblast function via disruption of the PI3K\/AKT and P53 signaling pathway, thus providing a mechanistic basis for its further exploration as a diagnostic marker and therapeutic target.\n                  <\/jats:p>","DOI":"10.1038\/s41536-026-00493-8","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:04:47Z","timestamp":1783429487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lumican deficiency dysregulates trophoblast function via PI3K\/AKT and P53 signaling in preeclampsia"],"prefix":"10.1038","volume":"11","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunzheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1161\/HYPERTENSIONAHA.119.14280","volume":"75","author":"LJJ Scheres","year":"2020","unstructured":"Scheres, L. J. J. et al. Hypertensive complications of pregnancy and risk of venous thromboembolism. Hypertension 75, 781\u2013787 (2020).","journal-title":"Hypertension"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","volume":"226","author":"O Erez","year":"2022","unstructured":"Erez, O. et al. Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am. J. Obstet. Gynecol. 226, S786\u2013S803 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"493_CR3","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet. Gynecol. 135, e237-e260 (2020).","DOI":"10.1097\/AOG.0000000000003891"},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","volume":"13","author":"MA Brown","year":"2018","unstructured":"Brown, M. A. et al. The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 13, 291\u2013310 (2018).","journal-title":"Pregnancy Hypertens."},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/1471-0528.14512","volume":"124","author":"MF van Oostwaard","year":"2017","unstructured":"van Oostwaard, M. F. et al. Maternal and neonatal outcomes in women with severe early onset pre-eclampsia before 26 weeks of gestation, a case series. BJOG 124, 1440\u20131447 (2017).","journal-title":"BJOG"},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell, L. C., Cluver, C. A., Kingdom, J. & Tong, S. J. Pre-eclampsia. Lancet Oncol. 398, 341\u2013354 (2021).","journal-title":"Lancet Oncol."},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","volume":"204","author":"I Brosens","year":"2011","unstructured":"Brosens, I., Pijnenborg, R., Vercruysse, L. & Romero, R. The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 204, 193\u2013201 (2011).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis, E. et al. Pre-eclampsia. Nat. Rev. Dis. Prim. 9, 8 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","volume":"226","author":"CWG Redman","year":"2022","unstructured":"Redman, C. W. G., Sargent, I. L. & Staff, A. C. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. Am. J. Obstet. Gynecol. 226, S907\u2013S927 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"493_CR10","first-page":"204.e201","volume":"224","author":"I Boucoiran","year":"2021","unstructured":"Boucoiran, I. et al. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study. Am. J. Obstet. Gynecol. 224, 204.e201\u2013204.e207 (2021).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"493_CR11","doi-asserted-by":"publisher","first-page":"10584","DOI":"10.3390\/ijms221910584","volume":"22","author":"CD Halari","year":"2021","unstructured":"Halari, C. D., Zheng, M. & Lala, P. K. Roles of two small leucine-rich proteoglycans decorin and biglycan in pregnancy and pregnancy-associated diseases. Int. J. Mol. Sci. 22, 10584 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"493_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1006\/geno.1995.1080","volume":"27","author":"S Chakravarti","year":"1995","unstructured":"Chakravarti, S., SundarRaj, S. R., Cornuet, N. & Hassell, P. K. JR. Primary structure of human lumican (keratan sulfate proteoglycan) and localization of the gene (LUM) to chromosome 12q21.3-q22. Genomics 27, 481\u2013488 (1995).","journal-title":"Genomics"},{"key":"493_CR13","doi-asserted-by":"publisher","first-page":"101042831769911","DOI":"10.1177\/1010428317699112","volume":"39","author":"S Appunni","year":"2017","unstructured":"Appunni, S. et al. Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): Plausible diagnostic marker in urothelial carcinoma of bladder. Tumour Biol. 39, 1010428317699112 (2017).","journal-title":"Tumour Biol."},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3389\/fphar.2019.01649","volume":"10","author":"X Pang","year":"2019","unstructured":"Pang, X., Dong, N. & Zheng, Z. Small leucine-rich proteoglycans in skin wound healing. Front. Pharmacol. 10, 1649 (2019).","journal-title":"Front. Pharmacol."},{"key":"493_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/cancers12010233","volume":"12","author":"K-C Hsiao","year":"2020","unstructured":"Hsiao, K.-C., Chu, P.-Y., Chang, G.-C. & Liu, K.-J. Elevated expression of lumican in lung cancer cells promotes bone metastasis through an autocrine regulatory mechanism. Cancers 12, 233 (2020).","journal-title":"Cancers"},{"key":"493_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2019.08.003","volume":"62","author":"K Karamanou","year":"2020","unstructured":"Karamanou, K., Franchi, M., Vynios, D. & Br\u00e9zillon, S. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator. Semin. Cancer Biol. 62, 125\u2013133 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"493_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1094-8","volume":"9","author":"C-T Yang","year":"2018","unstructured":"Yang, C.-T., Li, J.-M., Chu, W.-K. & Chow, S.-E. Downregulation of lumican accelerates lung cancer cell invasion through p120 catenin. Cell Death Dis. 9, 1040 (2018).","journal-title":"Cell Death Dis."},{"key":"493_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.tranon.2019.05.014","volume":"12","author":"W Mao","year":"2019","unstructured":"Mao, W. et al. Knockdown of lumican inhibits proliferation and migration of bladder cancer. Transl. Oncol. 12, 1072\u20131078 (2019).","journal-title":"Transl. Oncol."},{"key":"493_CR19","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1111\/febs.15289","volume":"287","author":"K Karamanou","year":"2020","unstructured":"Karamanou, K. et al. Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling. FEBS J. 287, 4862\u20134880 (2020).","journal-title":"FEBS J."},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"111598","DOI":"10.1016\/j.mce.2022.111598","volume":"547","author":"R Lai","year":"2022","unstructured":"Lai, R. et al. Stanniocalcin2 inhibits the epithelial-mesenchymal transition and invasion of trophoblasts via activation of autophagy under high-glucose conditions. Mol. Cell. Endocrinol. 547, 111598 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"493_CR21","doi-asserted-by":"publisher","first-page":"3147","DOI":"10.1007\/s43032-021-00660-w","volume":"28","author":"L C","year":"2021","unstructured":"C, L. et al. The downregulation of placental lumican promotes the progression of preeclampsia. Reprod. Sci. 28, 3147\u20133154 (2021).","journal-title":"Reprod. Sci."},{"key":"493_CR22","doi-asserted-by":"publisher","first-page":"615973","DOI":"10.3389\/fcell.2021.615973","volume":"9","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. STX2 promotes trophoblast growth, migration, and invasion through activation of the PI3K-AKT pathway in preeclampsia. Front. Cell Dev. Biol. 9, 615973 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biopha.2017.01.026","volume":"88","author":"C Liu","year":"2017","unstructured":"Liu, C. et al. Protein O-fucosyltransferase 1 promotes trophoblast cell proliferation through activation of MAPK and PI3K\/Akt signaling pathways. Biomed. Pharmacother. 88, 95\u2013101 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/REP-20-0156","volume":"160","author":"HQ Mo","year":"2020","unstructured":"Mo, H. Q. et al. PDIA3 regulates trophoblast apoptosis and proliferation in preeclampsia via the MDM2\/p53 pathway. Reproduction 160, 293\u2013305 (2020).","journal-title":"Reproduction"},{"key":"493_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.301","volume":"8","author":"F Wu","year":"2017","unstructured":"Wu, F. et al. Role of peroxiredoxin2 downregulation in recurrent miscarriage through regulation of trophoblast proliferation and apoptosis. Cell Death Dis. 8, e2908 (2017).","journal-title":"Cell Death Dis."},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1161\/HYPERTENSIONAHA.118.12389","volume":"73","author":"K Kawasaki","year":"2019","unstructured":"Kawasaki, K. et al. Metabolomic profiles of placenta in preeclampsia. Hypertension 73, 671\u2013679 (2019).","journal-title":"Hypertension"},{"key":"493_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/HYPERTENSIONAHA.111.00250","volume":"61","author":"AC Staff","year":"2013","unstructured":"Staff, A. C. et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension 61, 932\u2013942 (2013).","journal-title":"Hypertension"},{"key":"493_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119922","volume":"563","author":"M Adua","year":"2024","unstructured":"Adua, M. et al. Preeclampsia: a comprehensive review. Clin. Chim. Acta 563, 119922 (2024).","journal-title":"Clin. Chim. Acta"},{"key":"493_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1093526618803759","volume":"22","author":"J Stanek","year":"2019","unstructured":"Stanek, J. Histological features of shallow placental implantation unify early-onset and late-onset preeclampsia. Pediatr. Dev. Pathol. 22, 112\u2013122 (2019).","journal-title":"Pediatr. Dev. Pathol."},{"key":"493_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol, B. W. J. et al. Pre-eclampsia. Lancet 387, 999\u20131011 (2016).","journal-title":"Lancet"},{"key":"493_CR31","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3390\/biom11091319","volume":"11","author":"EM Giatagana","year":"2021","unstructured":"Giatagana, E. M., Berdiaki, A., Tsatsakis, A., Tzanakakis, G. N. & Nikitovic, D. Lumican in carcinogenesis-revisited. Biomolecules 11, 1319 (2021).","journal-title":"Biomolecules"},{"key":"493_CR32","doi-asserted-by":"publisher","first-page":"13181","DOI":"10.3390\/ijms232113181","volume":"23","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. et al. The anticancer effect of a novel quinoline derivative 91b1 through downregulation of lumican. Int. J. Mol. Sci. 23, 13181 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"493_CR33","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s13402-024-00919-9","volume":"47","author":"Y Tan","year":"2024","unstructured":"Tan, Y. et al. Repaglinide restrains HCC development and progression by targeting FOXO3\/lumican\/p53 axis. Cell. Oncol. 47, 1167\u20131181 (2024).","journal-title":"Cell. Oncol."},{"key":"493_CR34","doi-asserted-by":"publisher","unstructured":"Liu, H., Yu, L., Ding, Y., Peng, M. & Deng, Y. Progesterone Enhances the Invasion of Trophoblast Cells by Activating PI3K\/AKT Signaling Pathway to Prevent Preeclampsia. Cell Transplant. 32; https:\/\/doi.org\/10.1177\/09636897221145682 (2023).","DOI":"10.1177\/09636897221145682"},{"key":"493_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2024.01.008","volume":"147","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. OLFML3 suppresses trophoblast apoptosis via the PI3K\/AKT pathway: A possible therapeutic target in preeclampsia. Placenta 147, 1\u201311 (2024).","journal-title":"Placenta"},{"key":"493_CR36","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.3892\/mmr.2016.5659","volume":"14","author":"X Zhu","year":"2016","unstructured":"Zhu, X., Cao, Q., Li, X. & Wang, Z. Knockdown of TACC3 inhibits trophoblast cell migration and invasion through the PI3K\/Akt signaling pathway. Mol. Med. Rep. 14, 3437\u20133442 (2016).","journal-title":"Mol. Med. Rep."},{"key":"493_CR37","doi-asserted-by":"crossref","unstructured":"Frasch, M. G. et al. Preeclampsia Is Associated with Alterations in the p53-Pathway in Villous Trophoblast. PLoS ONE. 9, e87621 (2014).","DOI":"10.1371\/journal.pone.0087621"},{"key":"493_CR38","doi-asserted-by":"crossref","unstructured":"T, L., X, X., G, W. & biology, Y. J. J. B. p53-mediated suppression of the SLC7 A11\/GPX4 signaling pathway promotes trophoblast ferroptosis in preeclampsia. BMC Biol. 23, 141 (2025).","DOI":"10.1186\/s12915-025-02240-9"},{"key":"493_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115682","volume":"9","author":"S Gupta","year":"2014","unstructured":"Gupta, S. et al. Sinapic acid prevents hypertension and cardiovascular remodeling in pharmacological model of nitric oxide inhibited rats. PLoS ONE. 9, e115682 (2014).","journal-title":"PLoS ONE."},{"key":"493_CR40","doi-asserted-by":"publisher","first-page":"166317","DOI":"10.1016\/j.bbadis.2021.166317","volume":"1868","author":"L Panthiya","year":"2022","unstructured":"Panthiya, L. et al. Hexahydrocurcumin ameliorates hypertensive and vascular remodeling in L-NAME-induced rats. Acta Mol. Basis Dis. 1868, 166317 (2022).","journal-title":"Acta Mol. Basis Dis."},{"key":"493_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.niox.2017.04.009","volume":"67","author":"K Sonoda","year":"2017","unstructured":"Sonoda, K. et al. Dietary nitrite supplementation attenuates cardiac remodeling in l -NAME-induced hypertensive rats. Nitric Oxide 67, 1\u20139 (2017).","journal-title":"Nitric Oxide"},{"key":"493_CR42","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/biom13121792","volume":"13","author":"S Zeng","year":"2023","unstructured":"Zeng, S. et al. Improvement in clinical features of L-NAME-induced preeclampsia-like rats through reduced SERPINA5 expression. Biomolecules 13, 1792 (2023).","journal-title":"Biomolecules"},{"key":"493_CR43","doi-asserted-by":"publisher","first-page":"889","DOI":"10.21037\/atm-22-3675","volume":"10","author":"X Zhu","year":"2022","unstructured":"Zhu, X., Jiang, R., Ying, X., Li, Z. & Jiang, P. The role of ferritin and iron dextran in exacerbating preeclampsia in an L-NAME-treated rat model. Ann. Transl. Med. 10, 889 (2022).","journal-title":"Ann. Transl. Med."},{"key":"493_CR44","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s43032-021-00743-8","volume":"29","author":"H Wang","year":"2021","unstructured":"Wang, H., Li, M., Chen, P. & Shi, X. Anti-inflammatory and antioxidant effects of pyrroloquinoline quinone in L-name-induced preeclampsia-like rat model. Reprod. Sci. 29, 578\u2013585 (2021).","journal-title":"Reprod. Sci."}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00493-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00493-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:37:46Z","timestamp":1793317066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41536-026-00493-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1038\/s41536-026-00493-8","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"47"}}